Skip to main content

Advertisement

SpringerLink
Log in

Contribution of symptom clusters to multiple sclerosis consequences

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Purpose

There were two objectives in this study: (1) to identify, among women and men with MS, the extent to which different MS-related symptoms, including fatigue, pain, sleep disturbance, depression, anxiety, irritability, cognitive impairment, spasticity, and poor balance, cluster and (2) to compare the contribution of generated symptom clusters to MS consequences including functional walking capacity, perceived health, illness intrusiveness, and quality of life (QOL).

Methods

This was a cross-sectional study. A center-stratified random sample comprising 139 women and 49 men was recruited from three major MS clinics in Montreal. Subjects completed several self-report and performance-based measures that assessed symptoms and downstream MS consequences. Hierarchical and K-means cluster analyses were used to create clusters.

Results

Three symptom clusters were identified. Cluster 1, labeled the “emotional/cognitive symptom cluster,” comprised of depression, anxiety, cognitive impairments, and irritability. The second cluster, labeled the “physical symptom cluster,” included pain, fatigue, and sleep disorders. Cluster 3, labeled the “motor symptom cluster,” included spasticity and poor balance. Furthermore, the motor symptom cluster had a strong effect on functional walking capacity, while it did not affect significantly illness intrusiveness and QOL. On the other hand, the physical symptom clusters and emotional/cognitive symptom clusters showed a significant contribution to prediction of illness intrusiveness and QOL. All symptom clusters showed a significant effect in predicting the overall variability of perceived health status.

Conclusions

The findings of this study provide useful information to help healthcare professionals, clinicians, and researchers to target symptoms that are often in the same cluster when one or two of them are present. Identification of the strength of the contributions of each symptom clusters to the targeted MS consequences would further help to prioritize treatment approaches for the MS population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000). Multiple sclerosis. New England Journal of Medicine, 343, 938–952.

    Article  CAS  PubMed  Google Scholar 

  2. O’Connor, P. (2002). Key issues in the diagnosis and treatment of multiple sclerosis: An overview. Neurology, 59(6 Suppl. 3), S1–S33.

    Article  PubMed  Google Scholar 

  3. Lublin, F. D., & Reingold, S. C. (1996). Defining the clinical course of multiple sclerosis: results of an international survey. national multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology, 46(4), 907–911.

    Article  CAS  PubMed  Google Scholar 

  4. Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994). The impact of fatigue on patients with multiple sclerosis. Canadian Journal of Neurological Sciences, 21, 9–14.

    CAS  PubMed  Google Scholar 

  5. Ford, H., Trigwell, P., & Johnson, M. (1998). The nature of fatigue in multiple sclerosis. Journal of Psychosomatic Research, 45, 33–38.

    Article  CAS  PubMed  Google Scholar 

  6. Archibald, C. J., McGrath, P. J., & Ritvo, P. G. (1994). Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain, 58, 89–93.

    Article  CAS  PubMed  Google Scholar 

  7. Ehde, D. M., Gibbons, L. E., Chwastiak, L., Bombardier, C. H., Sullivan, M. D., & Kraft, G. H. (2003). Chronic pain in a large community sample of persons with multiple sclerosis. Multiple Sclerosis, 9, 605–611.

    Article  PubMed  Google Scholar 

  8. Kalia, L. V., & O’Connor, P. W. (2005). Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Multiple Sclerosis, 11, 322–327.

    Article  PubMed  Google Scholar 

  9. Svendsen, K. B., Jensen, T. S., Overvad, K., Hansen, H. J., KochHenriksen, N., & Bach, F. W. (2003). Pain in patients with multiple sclerosis. Archives of Neurology, 60, 1089–1094.

    Article  PubMed  Google Scholar 

  10. Svendsen, K. B., Jensen, T. S., Hansen, H. J., & Bach, F. W. (2005). Sensory function and quality of life in patients with multiple sclerosis and pain. Pain, 114, 473–478.

    Article  PubMed  Google Scholar 

  11. Bamer, A. M., Johnson, K. L., Amtmann, D., & Kraft, G. H. (2008). Prevalence of sleep problems in individuals with multiple sclerosis. Multiple Sclerosis, 14(8), 1127–1130.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Brass, S. D., Duquette, P., Proulx-Therrien, J., & Auerbach, S. (2010). Sleep disorders in patients with multiple sclerosis. Sleep Medicine Reviews, 14, 121–129.

    Article  PubMed  Google Scholar 

  13. Stanton, B. R., Barnes, F., & Silber, E. (2006). Sleep and fatigue in multiple sclerosis. Multiple Sclerosis, 12(4), 481–486.

    Article  CAS  PubMed  Google Scholar 

  14. Tachibana, N., Howard, R. S., Hirsch, N. P., Miller, D. H., Moseley, I. F., & Fish, D. (1994). Sleep problems in multiple sclerosis. European Neurology, 34(6), 320–323.

    Article  CAS  PubMed  Google Scholar 

  15. Grytten, N., & Maseide, P. (2006). ‘When I am together with them I feel more ill’. The stigma of multiple sclerosis experienced in social relationships. Chronic Illness, 2, 195–208.

    PubMed  Google Scholar 

  16. Leussink, V. I., Husseini, L., Warnke, C., Broussalis, E., Hartung, H. P., & Kieseier, B. C. (2012). Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Therapeutic Advances in Neurological Disorders, 5(5), 255–266.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Rao, S. M., Leo, G. J., Bernardin, L., & Unverzagt, F. (1991). Cognitive dysfunction in multiple sclerosis. Frequency, patterns, and prediction. Neurology, 41(5), 685–691.

    Article  CAS  PubMed  Google Scholar 

  18. Teng, S.Y., Bartlett, S., Koski, L., Chamelian, L., Duquette, P., Grand’Maison, F., Lapierre, Y., Mayo, N.E. (2009). Self-perceived and tested cognition in multiple sclerosis: Differences across gender. Journal of Multiple Sclerosis Clinical and Laboratory research, 15 (2).

  19. Feinstein, A. (2002). An examination of suicidal intent in patients with multiple sclerosis. Neurology, 59, 674–678.

    Article  PubMed  Google Scholar 

  20. Mohr, D. C. (2007). Stress and multiple sclerosis. Journal of Neurology, 254(2), II65–II68.

    PubMed  Google Scholar 

  21. Newland, P. K., Fearing, A., Riley, M., & Neath, A. (2012). Symptom clusters in women with relapsing-remitting multiple sclerosis. Journal of Neuroscience Nursing, 44(2), 66–71.

    Article  PubMed  Google Scholar 

  22. D’Alisa, S., Miscio, G., Baudo, S., Simone, A., Tesio, L., & Mauro, A. (2006). Depression is the main determinant of quality of life in multiple sclerosis: A classification-regression (CART) study. Disability and Rehabilitation, 28(5), 307–314.

    Article  PubMed  Google Scholar 

  23. Lovera, J., Bagert, B., Smoot, K. H., Wild, K., Frank, R., Bogardus, K., et al. (2006). Correlations of perceived deficits questionnaire of multiple sclerosis quality of life inventory with beck depression inventory and neuropsychological tests. Journal of Rehabilitation Research and Development, 43(1), 73–82.

    Article  PubMed  Google Scholar 

  24. DeLuca, J. (2006). What we know about cognitive changes in multiple sclerosis. In N. L. LaRocca & R. Kalb (Eds.), Multiple sclerosis: Understanding the cognitive changes (pp. 17–39). New York: Demos Medical Publishing.

    Google Scholar 

  25. Krupp, L. B. (2004). Fatigue in multiple sclerosis: A guide to diagnosis and management. New York, NY: Demos Medical Publishing.

    Google Scholar 

  26. Motl, R. W., Weikert, M., Suh, Y., & Dlugonski, D. (2010). Symptom cluster and physical activity in relapsing-remitting multiple sclerosis. Research in Nursing & Health, 33, 398–412.

    Article  Google Scholar 

  27. Kim, H. J., & Abraham, A. L. (2008). Statistical approaches to modeling symptom clusters in cancer patients. Cancer Nursing, 31, 162–220.

    Article  Google Scholar 

  28. Dodd, M. J., Miaskowski, C., & Paul, S. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28, 465–470.

    CAS  PubMed  Google Scholar 

  29. McSweeney, J. C., Cleves, M. A., Lefler, L., & Yang, S. (2010). Cluster analysis of women’s prodromal and acute myocardial infarction symptoms by race and other characteristics. Journal of Cardiovascular Nursing, 25(4), 311–322.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Miaskowski, C., Dodd, M., & Lee, K. (2004). Symptom clusters: The new frontier in symptom management research. Journal of National Cancer Institute Monographs, 32, 17–21.

    Article  Google Scholar 

  31. Miaskowski, C. (2006). Symptom clusters: establishing the link between clinical practice and symptom management research. Supportive Care in Cancer, 14, 792–794.

    Article  PubMed  Google Scholar 

  32. Motl, R. W., & McAuley, E. (2009). Symptom cluster as a predictor of physical activity in multiple sclerosis: Preliminary evidence. Journal of Pain and Symptom Management, 38, 270–280.

    Article  PubMed  Google Scholar 

  33. Motl, R. W., & McAuley, E. (2009). Pathways between physical activity and quality of life in adults with multiple sclerosis. Health Psychology, 28, 682–689.

    Article  PubMed  Google Scholar 

  34. Lenz, E. R., Pugh, L. C., Milligan, R. A., Gift, A., & Suppe, F. (1997). The middle-range theory of unpleasant symptoms: An update. Advances in Nursing Science, 19(3), 14–27.

    Article  CAS  PubMed  Google Scholar 

  35. Lenz, E. R., & Pugh, L. C. (2003). The theory of unpleasant symptoms. In M. J. Smith & P. R. Liehr (Eds.), Middle range theory for nursing (pp. 69–90). New York: Springer.

    Google Scholar 

  36. Given, C. W., Given, B., Azzouz, F., Kozachik, S., & Stommel, M. (2001). Predictors of pain and fatigue in the year following diagnosis among elderly cancer persons. Journal of Pain and Symptom Management, 6, 456–466.

    Article  Google Scholar 

  37. Given, B., Given, C. W., & McCorkle, R. (2002). Pain and fatigue management: results of a nursing randomized clinical trial. Oncology Nursing Forum, 29, 949–956.

    Article  PubMed  Google Scholar 

  38. Pearson, O. R., Busse, M. E., Van Deursen, R. W. M., & Wiles, C. M. (2004). Quantification of walking mobility in neurological disorders. Quarterly Journal of Medicine, 97(8), 463–475.

    Article  CAS  Google Scholar 

  39. Motl, R. W., Snook, E. M., McAuley, E., & Gliottoni, R. (2006). Symptoms, self-efficacy, and physical activity among individuals with multiple sclerosis. Research in Nursing & Health, 29, 597–606.

    Article  Google Scholar 

  40. Motl, R. W., Arnett, P. A., & Smith, M. M. (2008). Worsening of symptoms is associated with lower physical activity levels in individuals with multiple sclerosis. Multiple Sclerosis, 14, 140–142.

    Article  CAS  PubMed  Google Scholar 

  41. Motl, R. W., Snook, E. M., & Schapiro, R. T. (2008). Symptoms and physical activity behavior in individuals with multiple sclerosis. Research in Nursing & Health, 31, 466–475.

    Article  Google Scholar 

  42. Snook, E. M., & Motl, R. W. (2008). Physical activity behaviors in individuals with multiple sclerosis: Roles of overall and specific symptoms, and self-efficacy. Journal of Pain and Symptom Management, 36, 46–53.

    Article  PubMed  Google Scholar 

  43. Parkin, D., Rice, N., Jacoby, A., & Doughty, J. (2004). Use of a visual analogue scale in a daily person diary: Modelling cross-sectional time-series data on health-related quality of life. Social Science and Medicine, 59(2), 351–360.

    Article  PubMed  Google Scholar 

  44. Devins, G. M., Edworthy, S. M., Paul, L. C., Mandin, H., Seland, T. P., Klein, G., et al. (1993). Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. Journal of Psychosomatic Research, 37(2), 163–170.

    Article  CAS  PubMed  Google Scholar 

  45. Devins, G. M., Edworthy, S. M., Seland, T. P., Klein, G. M., Paul, L. C., & Mandin, H. (1993). Differences in illness intrusiveness across rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. The Journal of Nervous Mental Disease, 181(6), 377–381.

    Article  CAS  PubMed  Google Scholar 

  46. Devins, G. M. (1994). Illness intrusiveness and the psychosocial impact of lifestyle disruptions in chronic life-threatening disease. Advanced Renal Replacement Therapy, 1, 251–263.

    CAS  Google Scholar 

  47. Devins, G. M., Styra, R., O’Connor, P., Gray, T., Seland, T. P., & Klein, G. M. (1996). Psychosocial impact of illness intrusiveness moderated by age in multiple sclerosis. Psychology, Health & Medicine, 1, 179–191.

    Article  Google Scholar 

  48. Devins, G. M., Dion, R., Pelletier, L. G., Shapiro, C. M., Abbey, S., Raiz, L. R., et al. (2001). Structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the illness intrusiveness ratings scale. Medical Care, 39(10), 1097–1104.

    Article  CAS  PubMed  Google Scholar 

  49. Mullins, L. L., Cote, M. P., Fuemmeler, B. F., Jean, V. M., Beatty, W. W., & Paul, R. H. (2001). Illness intrusiveness, uncertainty, and distress in individuals with multiple sclerosis. Rehabilitation Psychology, 46(2), 139–153.

    Article  Google Scholar 

  50. Culp, D. (2010). Illness intrusiveness and sexual satisfaction among women with multiple sclerosis. Master of Arts Thesis in Psychology, Ryerson University.

  51. Turpin, K. V., Carroll, L. J., Cassidy, J. D., & Hader, W. J. (2007). Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs. Multiple Sclerosis, 13(8), 1038–1045.

    Article  CAS  PubMed  Google Scholar 

  52. Amato, M., Battaglia, M., & Caputo, D. (2002). The costs of multiple sclerosis: A cross-sectional, multicenter cost-of-illness study in Italy. Journal of Neurology, 249, 152–163.

    Article  PubMed  Google Scholar 

  53. Benedict, R., Wahlig, E., Bakshi, R., Fishman, I., Munschauer, F., & Weinstock-Guttman, B. (2005). Predicting quality of life in multiple sclerosis: Accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. Journal of the Neurological Sciences, 231(1, 2), 29–34.

    Article  PubMed  Google Scholar 

  54. Benito-Leon, J., Morales, J. M., & Rivera-Navarro, J. (2002). Health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis persons. European Journal of Neurology, 9, 497–502.

    Article  CAS  PubMed  Google Scholar 

  55. Egner, A., Phillips, V. L., Vora, R., & Wiggers, E. (2003). Depression, fatigue, and health-related quality of life among people with advanced multiple sclerosis: results from an exploratory telerehabilitation study. Neurorehabilitation, 18, 125–133.

    PubMed  Google Scholar 

  56. Janssens, A. C., Doorn, P. A., de Boer, J. B., Kalkers, N. F., Meche, F. G., & Passchier, J. (2003). Anxiety and depression influence the relation between disability status and quality of life in multiple sclerosis. Multiple Sclerosis, 9, 397–403.

    Article  CAS  PubMed  Google Scholar 

  57. Miller, D. M., Rudick, R. A., Baier, M., Cutter, G., Doughtery, D. S., & Weinstock-Guttman, B. (2003). Factors that predict health-related quality of life in persons with relapsing–remitting multiple sclerosis. Multiple Sclerosis, 9, 1–5.

    Article  PubMed  Google Scholar 

  58. O’Connor, P., Lee, L., Ng, P. T., Narayana, P., & Wolinsky, J. S. (2001). Determinants of overall quality of life in secondary progressive MS: A longitudinal study. Neurology, 57, 889–891.

    Article  PubMed  Google Scholar 

  59. Esper, P., & Heidrich, D. (2005). Symptom clusters in advanced illness. Seminars in Oncology Nursing, 21, 20–28.

    Article  PubMed  Google Scholar 

  60. Wilmoth, M. C., Coleman, E. A., Smith, S. C., & Davis, C. (2004). Fatigue, weight gain, and altered sexuality in persons with breast cancer: Exploration of a symptom cluster. Oncology Nursing Forum, 31, 1069–1075.

    Article  PubMed  Google Scholar 

  61. Armstrong, T. S., Cohen, M. Z., Eriksen, L. R., & Hickey, J. V. (2004). Symptom clusters in oncology persons and implications for symptom research in people with primary brain tumors. Journal of Nursing Scholarship, 36, 197–206.

    Article  PubMed  Google Scholar 

  62. Gift, A. G., Stommel, M., Jablonski, A., & Given, W. (2003). A cluster of symptoms over time in patients with lung cancer. Nursing Research, 52, 393–400.

    Article  PubMed  Google Scholar 

  63. Gift, A. G., Jablonski, A., Stommel, M., & Given, C. W. (2004). Symptom clusters in elderly patients with lung cancer. Oncology Nursing Forum, 31, 202–212.

    Article  PubMed  Google Scholar 

  64. Drew, M., Tippett, L. J., Starkey, N. J., & Isler, R. B. (2008). Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: A descriptive study. Archives of Clinical Neuropsychology, 23, 1–19.

    Article  PubMed  Google Scholar 

  65. Motl, R. W., Suh, Y., & Weikert, M. (2010). Symptom cluster and quality of life in multiple sclerosis. Journal of Pain and Symptom Management, 39(6), 1025–1032.

    Article  PubMed  Google Scholar 

  66. Nocentini, U., Pasqualetti, P., Bonavita, S., Buccafusca, M., De Caro, M. F., Farina, D., et al. (2006). Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis. Multiple Sclerosis, 12, 77.

    Article  CAS  PubMed  Google Scholar 

  67. Kurtzke, J. F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33(11), 1444–1452.

    Article  CAS  PubMed  Google Scholar 

  68. Hays, R. D., & Morales, L. S. (2001). The RAND-36 measure of health- related quality of life. Annals of Medicine, 33, 350–357.

    Article  CAS  PubMed  Google Scholar 

  69. Brunet, D. G., Hopman, W. M., Singer, M. A., Edgar, C. M., & MacKenzie, T. A. (1996). Measurement of health-related quality of life in multiple sclerosis patients. The Canadian Journal of Neurological Sciences, 23(2), 99–103.

    CAS  PubMed  Google Scholar 

  70. Freeman, J. A., Hobart, J. C., Langdon, D. W., & Thompson, A. J. (2000). Clinical appropriateness: A key factor in outcome measure selection: The 36 item short form health survey in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 68, 150–156.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-item short-form health survey (SF-36): II. A psychometric and clinical test of validity in measuring physical and mental health constructs. Medical Care, 31, 247–263.

    Article  CAS  PubMed  Google Scholar 

  72. McHorney, C. A., Ware, J. E., & Sherbourne, C. D. (1994). The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32, 40–66.

    Article  CAS  PubMed  Google Scholar 

  73. Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193–213.

    Article  CAS  PubMed  Google Scholar 

  74. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.

    Article  CAS  PubMed  Google Scholar 

  75. Herrmann, C. (1997). International experiences with the hospital anxiety and depression scale-a review of validation data and clinical results. Journal of Psychosomatic Research, 42(1), 17–41.

    Article  CAS  PubMed  Google Scholar 

  76. Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale; an updated review. Journal of Psychosomatic Research, 52(2), 69–77.

    Article  PubMed  Google Scholar 

  77. da Silva, A. M., Vilhena, E., Lopes, A., & Santos, E. (2011). Depression and anxiety in a Portuguese MS population: Associations with physical disability and severity of disease. Journal of the Neurological Sciences, 306(15), 66–70.

    Article  PubMed  Google Scholar 

  78. Honarmand, K., & Feinstein, A. (2009). Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients. Multiple Sclerosis, 15(12), 1518–1524.

    Article  PubMed  Google Scholar 

  79. Ilfeld, F. W, Jr. (1976). Further validation of a psychiatric symptom index in a normal population. Psychological Reports, 39, 1215–1228.

    Article  Google Scholar 

  80. Sullivan, M. J. L., Edgley, K., & Mikail, S. (1993). Psychological correlates of health care utilization in chronic illness. Canadian Journal of Rehabilitation, 6, 13–21.

    Google Scholar 

  81. Shevil, E., & Finlayson, M. (2006). Perceptions of persons with multiple sclerosis on cognitive changes and their impact on daily life. Disability and Rehabilitation, 28(12), 779–788.

    Article  PubMed  Google Scholar 

  82. Marrie, R. A., Miller, D. M., Chelune, G. J., & Cohen, J. A. (2003). Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis. Multiple Sclerosis, 9(6), 621–626.

    Article  PubMed  Google Scholar 

  83. Bohannon, R., & Smith, M. (1987). Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy, 67(2), 206–207.

    CAS  PubMed  Google Scholar 

  84. Ashworth, B. (1964). Preliminary trial of carisoprodal in multiple sclerosis. The Practitioner, 192, 540–542.

    CAS  PubMed  Google Scholar 

  85. Leslie, G. C., Muir, C., Part, N. J., & Roberts, R. C. (1992). A comparison of the assessment of spasticity by the Wartenberg pendulum test and the Ashworth grading scale in patients with multiple sclerosis. Clinical Rehabilitation, 6, 41–48.

    Article  Google Scholar 

  86. Nuyens, G., De Weerdt, W., Ketelaer, P., Feys, H., De Wolf, L., Hantson, L., Nieuboer, A., Spaepen, A., & Carton, H. (1994). Inter-rater reliability of the Ashworth scale in multiple Sclerosis. Clinical Rehabilitation, 8, 286–292.

  87. Pandyan, A. D., Price, C. I. M., & Curless, R. H. (1999). A review of the properties and limitations of the Ashworth & modified Ashworth Scales. Clinical Rehabilitation, 13(5), 373–383.

    Article  CAS  PubMed  Google Scholar 

  88. Pandyan, A. D., Price, C. I. M., & Rodgers, H. (2001). Biomechanical examination of a commonly used measure of spasticity. Clinical Biomechanics, 16, 859–865.

    Article  CAS  PubMed  Google Scholar 

  89. Tesio, L., Perucca, L., Franchignoni, F. P., & Battaglia, M. A. (1997). A short measure of balance in multiple sclerosis: validation through Rasch analysis. Functional Neurology, 12(5), 255–265.

    CAS  PubMed  Google Scholar 

  90. Butland, R. J. A., Pang, J., Gross, E. R., Woodcock, A. A., & Geddes, D. M. (1982). Two-, six- and 12-minute walking tests in respiratory disease. British Medical Journal, 284, 1607–1608.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  91. Savci, S., InalInce, D., & Arikan, H. (2005). Six-minute walk distance as a measure of functional exercise capacity in multiple sclerosis. Disability and Rehabilitation, 27(22), 1365–1371.

    Article  PubMed  Google Scholar 

  92. Goldman, M., Marrie, R. A., & Cohen, J. A. (2007). Evaluation of six minutes walk test in MS and healthy population. Multiple Sclerosis, 14, 383–390.

    Article  PubMed  Google Scholar 

  93. Morales, F. J., Martinez, A., Mendez, M., Agarrado, A., Ortega, F., & Fernandez-Guerra, J. (1999). A shuttle walk test for assessment of functional capacity in chronic heart failure. Americal Heart Journal, 138(2), 291–298.

  94. Paltamaa, J., West, H., Sarasoja, T., Wikstrom, J., & Malkia, E. (2005). Reliability of physical functioning measures in ambulatory subjects with MS. Physiotherapy Research International, 10(2), 93–109.

    Article  PubMed  Google Scholar 

  95. EuroQol Group. (1990). EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16(3), 199–208.

    Article  Google Scholar 

  96. Nortvedt, M., Riise, T., & Myhr, K. (1999). Quality of life in multiple sclerosis: measuring the disease effects more. Neurology, 53, 1098–1103.

    Article  CAS  PubMed  Google Scholar 

  97. Devins, G. M., Binik, Y. M., Hutchinson, T. A., Hollomby, D. J., Barré, P. E., & Guttmann, R. D. (1983). The emotional impact of end-stage renal disease: Importance of persons’ perceptions of intrusiveness and control. The International Journal of Psychiatry in Medicine, 13(4), 1983–1984.

    Article  Google Scholar 

  98. Devins, G. M. (2010). Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease. Journal of Psychosomatic Research, 68(6), 591–602.

    Article  PubMed  Google Scholar 

  99. Ruta, D. A., Garratt, A. M., Leng, M., Russell, I. T., & MacDonald, L. M. (1994). A new approach to the measurement of quality of life. the person-generated index. Medical Care, 32, 1109–1126.

    Article  CAS  PubMed  Google Scholar 

  100. Ruta, D. A., Garratt, A. M., & Russell, I. T. (1999). Person centred assessment of quality of life for persons with four common conditions. Qualitative Health Care, 8, 22–29.

    Article  CAS  Google Scholar 

  101. Lintern, T. C., Beaumont, J. G., Kenealy, P. M., & Murrell, R. C. (2001). Quality of life (HRQL) in severely disabled multiple sclerosis persons: Comparison of three HRQL measures using multidimensional scaling. Quality of Life Research, 10, 371–378.

    Article  CAS  PubMed  Google Scholar 

  102. Garratt, A. M., & Ruta, D. A. (1999). The person generated index. In C. R. B. Joyce, C. A. O’Boyle, & H. McGee (Eds.), Individual quality of life: Approaches to conceptualization and assessment (pp. 105–118). Amsterdam: Harwood Academic Publishers.

    Google Scholar 

  103. Anderberg, M. R. (1973). Cluster Analysis for Applications. New York: Academic Press Inc.

    Google Scholar 

  104. Everitt, B. S., Landau, S., & Leese, M. (2001). Cluster analysis. New York: Oxford University Press.

    Google Scholar 

  105. Hopman, W. M., Towheed, T., Anastassiades, T., Tenenhouse, A., Poliquin, S., Berger, C., et al. (2000). Canadian normative data for the SF-36 health survey. Canadian Medical Association Journal, 163(3), 265–271.

    PubMed Central  CAS  PubMed  Google Scholar 

  106. Enright, P. (2003). The six-minute walk test. Respiratory care, 48(8), 783–785.

    PubMed  Google Scholar 

  107. Mayo, N., Goldberg, M.S., Kind, P. (1997). Calibrating the EQ-5D for a Canadian Population. In: Proceedings from EuroQol Plenary Meeting, Center for Health Policy and Law, Erasmus University, Rotterdam, The Netherlands. pp. 25–40.

  108. Redelmeier, D., Bayoumi, A., Goldstein, R., & Guyatt, G. (1997). Interpreting small differences in functional status: the six minute walk test in chronic lung disease persons. American Journal of Respiratory and Critical Care Medicine, 155, 1278–1282.

    Article  CAS  PubMed  Google Scholar 

  109. Fox, S. W., & Lyon, D. E. (2006). Symptom clusters and quality of life in survivors of lung cancer. Oncology Nursing Forum, 33, 931–936.

    Article  PubMed  Google Scholar 

  110. Kelley, K. W., Bluthé, R. M., Dantzer, R., Zhou, J. H., Shen, W. H., Johnson, R. W., et al. (2003). Cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 17(Suppl 1), S112–S118.

    Article  CAS  PubMed  Google Scholar 

  111. Mayo, N. (2008). Setting the agenda for multiple sclerosis rehabilitation research. Multiple Sclerosis, 14(9), 1154–1156.

    Article  PubMed  Google Scholar 

  112. Kirkova, J. K., Aktas, A., Walsh, D., & Davis, M. P. (2011). Cancer symptom clusters: Clinical and research methodology. Journal of Palliative Medicine, 14(10), 1149–1166.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a scholarship from the Canadian Institutes of Health Research. Authors acknowledge the contribution of Élaine Roger, who recruited patients from Centre Hospitalier de l’Université de Montréal.

Ethical standard

Study protocol and procedures were approved by the ethics committee of each participating hospital; informed consent was obtained and signed by all subjects on the day of testing.

Author information

Authors and Affiliations

  1. Faculty of Medicine, School of Physical and Occupational Therapy, McGill University, Montreal, Canada

    Shahnaz Shahrbanian, Ayse Kuspinar & Nancy E. Mayo

  2. Notre-Dame Hospital (CHUM), University of Montreal, Montreal, Canada

    Pierre Duquette

  3. Division of Clinical Epidemiology, McGill University Health Center, Royal Victoria Hospital Site, Ross Pavilion R4.27, 687 Pine Ave W, Montreal, QC, H3A 1A1, Canada

    Nancy E. Mayo

  4. Faculty of Physical Education and Sport Science, Buali Sina University, Hamedan, IRAN

    Shahnaz Shahrbanian

Authors
  1. Shahnaz Shahrbanian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre Duquette
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ayse Kuspinar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nancy E. Mayo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shahnaz Shahrbanian.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shahrbanian, S., Duquette, P., Kuspinar, A. et al. Contribution of symptom clusters to multiple sclerosis consequences. Qual Life Res 24, 617–629 (2015). https://doi.org/10.1007/s11136-014-0804-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-014-0804-7

Keywords

Search

Navigation